Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Kurozumi A, Hatazaki M, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ryomoto K, Kato K, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I; UTOPIA study investigators. Katakami N, et al. Among authors: kaneto h. Cardiovasc Diabetol. 2023 Jun 22;22(1):143. doi: 10.1186/s12933-023-01879-4. Cardiovasc Diabetol. 2023. PMID: 37349722 Free PMC article. Clinical Trial.
Correlation of Baba's diabetic neuropathy classification with various diabetes-related complications.
Iwamoto Y, Nakanishi S, Itoh T, Nakao E, Sugisaki T, Kusano T, Ohnishi M, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Hemmi S, Kimura T, Tatsumi F, Shimoda M, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: kaneto h. Front Endocrinol (Lausanne). 2022 Oct 27;13:1054934. doi: 10.3389/fendo.2022.1054934. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36387868 Free PMC article.
Influence of Nutritional Guidance/Consulting on Glycemic Control during the Coronavirus Disease 2019 Pandemic in Patients with Type 2 Diabetes Mellitus.
Iwamoto Y, Nakanishi S, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Kimura T, Tatsumi F, Shimoda M, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: kaneto h. Intern Med. 2023 Mar 15;62(6):833-838. doi: 10.2169/internalmedicine.1055-22. Epub 2023 Jan 12. Intern Med. 2023. PMID: 36631097 Free PMC article.
Efficacy and safety of pemafibrate in patients with hypertriglyceridemia in clinical settings: A retrospective study.
Katakura Y, Shimoda M, Ohnishi M, Kusano T, Dan K, Isobe H, Wamata R, Iwamoto Y, Fushimi Y, Sanada J, Obata A, Kimura T, Tatsumi F, Nakanishi S, Mune T, Kaku K, Kaneto H. Katakura Y, et al. Among authors: kaneto h. Nutr Metab Cardiovasc Dis. 2023 Jul;33(7):1444-1452. doi: 10.1016/j.numecd.2023.02.011. Epub 2023 Feb 21. Nutr Metab Cardiovasc Dis. 2023. PMID: 37246074 Free article.
Immune checkpoint inhibitor-induced hypothyroidism predicts treatment response in Japanese subjects.
Iwamoto Y, Kimura T, Dan K, Ohnishi M, Takenouchi H, Iwamoto H, Sanada J, Fushimi Y, Katakura Y, Shimoda M, Nakanishi S, Mune T, Kaku K, Kaneto H. Iwamoto Y, et al. Among authors: kaneto h. Front Endocrinol (Lausanne). 2023 Jul 31;14:1221723. doi: 10.3389/fendo.2023.1221723. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37583431 Free PMC article.
Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study).
Kimura T, Katakura Y, Shimoda M, Kawasaki F, Yamabe M, Tatsumi F, Matsuki M, Iwamoto Y, Anno T, Fushimi Y, Kamei S, Kimura Y, Nakanishi S, Mune T, Kaku K, Kaneto H; COMING study Group. Kimura T, et al. Among authors: kaneto h. Diabetes Obes Metab. 2023 Dec;25(12):3632-3647. doi: 10.1111/dom.15258. Epub 2023 Aug 30. Diabetes Obes Metab. 2023. PMID: 37646192 Clinical Trial.
606 results